13F

Stock

Corvus Pharmaceuticals, Inc.

CRVS · held by 1 managers

Reported value

$24.6K

Holders

1

+0 new · −0 exited

Holders’ est. mark

−$770

Price effect on 1 books still in the name

Largest holder

$24.6K

Leonteq Securities AG

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Leonteq Securities AG15K$24.6K−$770Added$22.2K

Positions as of Q1 2022. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.